A consumer has sued Chobani in federal court in New York over the way the company markets and labels its food. The claim is that Chobani links its products to GLP-1 medications and to weight loss when the products are not proven to work that way.
The case is Lombardo v. Chobani LLC, filed in the Southern District of New York. It is pending, which means it has been started and nothing has been decided. The full allegations are not in the public court record yet, so what the shopper says was on the label, and where, is not something anyone can read for themselves today.
Suits like this one are brought under consumer protection and false advertising law, and they turn on a narrow question: whether an ordinary buyer would read the packaging as a promise the product cannot keep. It is not a case about whether the food is healthy or whether GLP-1 medications work. It is about what the box says.
If Chobani loses or settles, the usual outcomes are a change to the marketing, damages, or both. If it wins, the labels stay as they are. Either way, no judge has ruled and no settlement has been announced.
Food marketing has been crowding toward GLP-1 language for two years now, with high protein lines, portion sized packs and shelf tags aimed at people on these drugs. This is one of the first cases to test how far that language can go before it has to be backed with evidence, which is why it is worth following even though it changes nothing this week.
Nothing about anyone's prescription, pharmacy or coverage changes because of this case. What it is worth is the precedent: a court is being asked to draw the line between food that suits a GLP-1 routine and food sold as if it worked like one.
Key details
A consumer has sued Chobani in federal court in New York over the marketing and labeling of its food.
The claim is that Chobani connects its products to GLP-1 medications and to weight loss when they are not proven to work that way.
The case is Lombardo v. Chobani LLC, in the Southern District of New York, and it is pending.
The full allegations are not in the public court record yet, and no judge has ruled and no settlement has been announced.
Nothing about anyone's prescription, pharmacy or coverage changes because of this case.
Sources
CourtListener: Lombardo v. Chobani LLC, docket 74726107 (S.D.N.Y.)
Originally published on GLP-1 Laws.
Every Sunday, the weekly newsletter pulls the full week together: the news from GLP-1 Nation, the access updates from GLP1Laws, the latest GLP-1 Studio podcast episodes, and what changed in the Cozy Butter community.